pharma & healthcare

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

April 28, 2022 — Episode 7: The Empowered Patient Journey (pt 1), a conversation with Nina Wachsman, CEO/Co-Founder of Know Rare.

Over the last couple of years, the pandemic has evoked massive disruption to all part of our lives, including our healthcare system, and this has drastically changed today’s patient journey. In the first of our two-part series, the Empowered Patient Journey, guest host Kelly Lundquist, Senior Vice President and Head Of Health Strategy North America at Havas Media, and CEO/Co-Founder of Know Rare Nina Wachsman discuss how the confluence of these behavioral changes by both patients and brands is giving rise to heightened patient expectations when it comes to healthcare.

Guest: Nina Wachsman, CEO/Co-Founder of Know Rare

For more information on Know Rare, check out our site: www.knowrare.com
To contact us please reach out to Liz Kay, Business Development and Partnerships: Liz@knowrare.com

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

May 25, 2022 — Episode 8: The Empowered Patient Journey (pt 2), a conversation with Nina Wachsman, CEO/Co-Founder of Know Rare.

The COVID pandemic, which hit us in March 2020, has changed our lives in many ways, including how we deal with healthcare. In the second of our two-part series, the Empowered Patient Journey, guest host Kelly Lundquist, Senior Vice President and Head Of Health Strategy North America at Havas Media, interviews a panel of experts on how patients can navigate the complex healthcare system to find the right doctors, support groups and care that works for them.

Guests:
Nina Wachsman, CEO/Co-Founder of Know Rare
Rob Weker, patient and cancer survivor
Patrick Howie, Founder and CEO of MediFind

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

June 30, 2022 — Episode 9: Four Tensions Driving the Future of Wellness, a conversation with, Matt Carmichael, Senior Vice President at Ipsos where he heads the Ipsos Trends and Foresight Lab, and Editor of Ipsos’ magazine, What the Future.

Some trends in health care grow out of Americans’ attitudes towards health and wellness. Ipsos, one of the world’s largest and most esteemed market research companies, has been monitoring these trends and attitudes. Those trends reveal occasional tensions between attitudes and our current health and wellness environment and between various sectors of the us population. Four of these tensions are outlined in an article in the latest issue of What the Future.

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

July 28, 2022 — Episode 10: Patient Segmentation, a conversation with, Kelly Peters, Vice President of the Marketing Center of Excellence within IQVIA Commercial Solutions and Mandy Rexroat, Senior Vice President, Group Account Director at 21GRAMS, part of Real Chemistry

Patient segmentation is a process of dividing people with a particular health condition into groups based on their diagnosis, behavior, lifestyle, and needs. Guest host Anna Bradfield, ARF Pharma Council member and SVP Brand Strategy at Wunderman Thompson Health, leads our discussion of the benefits of patient segmentation and how it’s evolving.

Consumer Behavioral Shifts: Why Your Marketing Measurement Must Adapt in 2022 and Beyond (Event Summary)

Consumer Behavioral Shifts: Why Your Marketing Measurement Must Adapt in 2022 and Beyond (Event Summary)

  • Insights Studio

Consumer behaviors have changed dramatically creating new challenges for brands and their marketing measurement. During this Insights Studio, we explored the measurement challenges brands have faced in the wake of significant consumer changes. We also discussed best practices brands should be using to ensure their marketing measurement is set up for future success as consumers continue to react to major societal change. Executives from OptiMine, an agile marketing analytics provider, Kepler, a global digital agency, and Beachbody, an innovative health and fitness company, shared their observations on how changes in consumer shopping and media consumption behaviors have been reflected in marketing measurement.

Member Only Access
Does Animation Help or Hurt Rx Drug Ads?

Does Animation Help or Hurt Rx Drug Ads?

  • JOURNAL OF ADVERTISING RESEARCH

Animated and rotoscoped characters in television commercials can affect consumers differently than live actors. But in direct-to-consumer ads for prescription drugs (which convey risks and benefits), can these characters alter the ways people process the information and therefore, their perceptions about the brand and the ad? A new study has some surprising findings and opens the door to further research.

  • Article

JAR: What’s the Best Format for “Supers” in DTC TV Ads?

In a study on formatting characteristics in direct-to-consumer, prescription-drug advertising, the adage ”God is in the details” rings loud and true. TV and online video ads use superimposed text to convey additional information about a drug’s risks and benefits. But, researchers asked, how much can details like text size and contrast affect awareness and attitudes? View article.

What’s the Best Format for “Supers” in DTC TV Ads?

What’s the Best Format for “Supers” in DTC TV Ads?

  • JOURNAL OF ADVERTISING RESEARCH

In a study on formatting characteristics in direct-to-consumer, prescription-drug advertising, the adage ”God is in the details” rings loud and true. TV and online video ads use superimposed text to convey additional information about a drug’s risks and benefits. But, researchers asked, how much can details like text size and contrast affect awareness and attitudes?

« Prev Next »